Clinical trials
Polymyositis trials in Poland
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
9 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2013 | 1 |
| 2018 | 1 |
| 2022 | 1 |
| 2023 | 3 |
| 2024 | 1 |
| 2025 | 2 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Recruiting | 4 |
| Completed | 2 |
| Terminated | 2 |
| Enrolling by invitation | 1 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Pfizer | 2 |
| argenx | 2 |
| Amgen | 1 |
| AstraZeneca | 1 |
| EMD Serono Research & Development Institute, Inc. | 1 |
| Juno Therapeutics, Inc., a Bristol-Myers Squibb Company | 1 |
| Novartis Pharmaceuticals | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Polymyositis | 9 |
| Dermatomyositis | 8 |
| Myositis | 6 |
| Lupus Erythematosus, Systemic | 2 |
| Scleroderma, Systemic | 2 |
| Arthritis, Rheumatoid | 1 |
| Autoimmune Diseases | 1 |
| Connective Tissue Diseases | 1 |
| Lupus Erythematosus, Cutaneous | 1 |
| Lupus Nephritis | 1 |
Trials
Showing 1 to 9 of 9. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.